Pfizer warns of ‘constant waves’ of Covid as complacency grows:
ft.com/content/8244af52-26ba-4676-961a-c57f1d4892e8
Story Details
| Last Updated | May 26 22 |
| Total Articles | 11 |
News on this topic
Pfizer warns of ‘constant waves’ of Covid as complacency grows: Chief executive Albert Bourla launches plan to offer patented medicines at lower cost to poorer ...
ft.com/content/8244af52-26ba-4676-961a-c57f1d4892e8
Pfizer CEO predicts 'constant waves' of COVID-19, blames complacency: The consequences of people's hesitancy to wear masks and get vaccinated will likely be seen ...
businessinsider.com/pfizer-ceo-constant-waves-covid-19-coronavirus-complacency-albert-bourla-2022-5
More articles on this subject
Previous
Pfizer warns of ‘constant waves’ of Covid as complacency grows: Chief executive Albert Bourla launches plan to offer patented medicines at lower cost to poorer ...
ft.com/content/8244af52-26ba-4676-961a-c57f1d4892e8
Pfizer CEO predicts 'constant waves' of COVID-19, blames complacency: The consequences of people's hesitancy to wear masks and get vaccinated will likely be seen ...
businessinsider.com/pfizer-ceo-constant-waves-covid-19-coronavirus-complacency-albert-bourla-2022-5
COVID-19 booster shots available for ages 5 and up in Sonoma County: Federal officials have granted emergency use authorization for Pfizer-BioNTech’s booster ...
pressdemocrat.com/article/news/covid-19-booster-shots-available-for-ages-5-and-up-in-sonoma-county/
Has the US Damaged Africa’s COVID-19 Vaccination Drive? | by Ebere Okereke - Project Syndicate
project-syndicate.org/commentary/us-fda-covid19-vaccine-restriction-impact-on-africa-by-ebere-okereke-2022-05
WEF video with Pfizer boss goes viral: But the snippet is four years old: At the WEF 2018, the Pfizer boss is talking about tablets with a biological chip ...
handelszeitung.ch/musterportfolios/wef-video-mit-pfizer-chef-geht-viral-doch-der-schnipsel-ist-vier-jahre-alt
Covid pill is being developed at Pfizer in Freiburg after express development...: Six months from the idea to production: The corona drug Paxlovid is ...
badische-zeitung.de/covid-pille-wird-bei-pfizer-in-freiburg-nach-express-entwicklung-hergestellt
Pfizer vs Moderna battle over COVID vaccine patents begins in UK: Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-vs-moderna-battle-over-covid-vaccine-patents-begins-uk-2024-04-23/
Corona: Low demand for vaccines causes a massive drop in profits at Pfizer: Last year, demand for corona drugs fell significantly. The US group's revenue fell by ...
berliner-zeitung.de/news/corona-geringe-impfstoff-nachfrage-sorgt-fuer-massiven-gewinneinbruch-bei-pfizer-li.2182119
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
cnbc.com/2024/03/10/pfizer-is-betting-big-on-cancer-drugs-after-covid-decline.html
Pfizer: Lost All Of Its Covid Glory, But Don't Give Up Now: Pfizer remains committed to maintaining its dividend and posting solid profitability ...
seekingalpha.com/article/4658260-pfizer-lost-all-of-its-covid-glory-but-dont-give-up-now
Paid articlePaid
Covid Vaccines Linked To Small Increase In Heart And Brain Disorders, Study Finds—But Risk From Infection Is Far Higher
forbes.com/sites/ariannajohnson/2024/02/19/covid-vaccines-linked-to-small-increase-in-heart-and-brain-disorders-study-finds-but-risk-from-infection-is-far-higher/
Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.: With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use ...
nytimes.com/2024/01/04/health/paxlovid-covid-treatment.html
Paxton sues Pfizer for not ending pandemic sooner: Experts argue other assertions made in the lawsuit filing are completely unsubstantiated ...
texastribune.org/2023/11/30/texas-attorney-general-pfizer-lawsuit/
Ex-Pfizer employee convicted of insider trading on COVID drug trial: A former employee of Pfizer Inc (PFE.N) was convicted of insider trading on Thursday for ...
reuters.com/business/healthcare-pharmaceuticals/ex-pfizer-employee-convicted-insider-trading-covid-drug-trial-2024-01-18/
Pfizer has turned to multi-billion deals, an internal restructuring and a massive cost-cutting program as the U.S
reuters.com/business/healthcare-pharmaceuticals/how-pfizer-is-fortifying-growth-beyond-covid-products-2023-12-13/
What To Know About Adcetris—Pfizer’s Cancer Drug Extended Survival For Patients With Common Lymphoma
forbes.com/sites/tylerroush/2024/03/12/what-to-know-about-adcetris-pfizers-cancer-drug-extended-survival-for-patients-with-common-lymphoma/
Pfizer Is Not Cheap, And The 5.7% Yield Is Not As Safe As You Might Think: Is now the right time to invest in Pfizer's stock? Click here to find out why ...
seekingalpha.com/article/4658881-pfizer-is-not-cheap-and-the-5-7-percent-yield-is-not-as-safe-as-you-might-think
Paid articlePaid Ex-Pfizer employee convicted of insider trading on COVID drug trial: A former employee of Pfizer Inc (PFE.N) was convicted of insider trading on Thursday for ...
reuters.com/business/healthcare-pharmaceuticals/ex-pfizer-employee-convicted-insider-trading-covid-drug-trial-2024-01-18/
Ex-Pfizer Employee Convicted of Insider Trading on Covid Pill: A former Pfizer Inc. employee was convicted of using confidential information about the company’s ...
bloomberg.com/news/articles/2024-01-18/ex-pfizer-employee-convicted-of-insider-trading-on-covid-pill
Paid articlePaid Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.: With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use ...
nytimes.com/2024/01/04/health/paxlovid-covid-treatment.html
Pfizer: The Bears Have Won This Round: An analysis of Pfizer's financial decisions, including overpaying for acquisitions, potential inventory write-downs ...
seekingalpha.com/article/4658187-pfizer-bears-have-won-this-round
Paid articlePaid
Pfizer shares slump 7% as pandemic product sales fizzle: US drugmaker employs 4,000 people between Kildare, Dublin, and Ringaskiddy and has in the recent past ...
irishexaminer.com/business/companies/arid-41289706.html
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
qz.com/novavax-covid19-mrna-1851410267
Quick Glance: Criticism of Novavax for Missed Opportunities in Boosting COVID-19 Vaccine Sales
- Shah Capital called for immediate changes in the company's board.
- The activist hedge fund Shah Capital criticized Novavax's leadership for not capitalizing on concerns some individuals have about mRNA vaccines to increase sales of its traditional, protein-based COVID-19 vaccine.
- Findings from a survey of 1,500 Americans by the Annenberg Public Policy Center (APPC) at the University of Pennsylvania revealed an increase in the spread of vaccine misinformation.
- The limited use of COVID-19 vaccines is also affecting other vaccine manufacturers. In the U.S., only 14% of adults have received an updated COVID-19 vaccine for 2023-2024, according to the Centers for Disease Control and Prevention.
Pfizer: Not A Bad Time To Start A Position And Add On Further Weakness: Pfizer offers a potential long-term investment with manageable debt and a solid portfolio ...
seekingalpha.com/article/4658427-pfizer-stock-not-bad-time-to-start-position-add-weakness
Paid articlePaid
Ex-Pfizer Employee Netted $270,000 In Covid-Tied Insider Trading: A former Pfizer employee profited to the tune of $270,000 in an insider-trading scheme tied to ...
investors.com/news/technology/pfizer-stock-ex-employee-found-guilty-in-paxlovid-tied-insider-trading-scheme/
Pfizer Covid Drug Doses Set to Expire to Cost Europe $2.2 Billion: Stockpiles of Pfizer Inc.’s Paxlovid worth $2.2 billion are set to expire by the end of next ...
bloomberg.com/news/articles/2024-01-02/expiring-pfizer-covid-drug-doses-set-to-cost-europe-2-2-billion
Paid articlePaid How Pfizer is fortifying for growth beyond COVID products
reuters.com/business/healthcare-pharmaceuticals/how-pfizer-is-fortifying-growth-beyond-covid-products-2023-12-13/
Pfizer’s answer to tumbling stock is focusing on crowded cancer drug market: Since the end of 2022, Pfizer's shares have fallen 42% as the company has repeatedly ...
bloomberg.com/news/articles/2024-01-09/pfizer-ceo-albert-bourla-sees-cancer-drugs-as-key-to-comeback
Paid articlePaid Pfizer Covid Boosters Aren't Strong Enough Against Omicron: Pfizer is struggling because not enough people are getting annual Covid shots ...
bloomberg.com/opinion/articles/2023-12-19/pfizer-covid-boosters-aren-t-strong-enough-against-omicron
Paid articlePaid Pfizer Shares Drop After Drugmaker Drops Experimental Weight-Loss Pill: Pfizer Inc.’s second weight-loss setback this year is a warning sign that breaking into ...
bloomberg.com/news/articles/2023-12-01/pfizer-drops-twice-daily-weight-loss-pill-due-to-side-effects
Paid articlePaid
Older Americans advised to get another Covid shot this spring: Most Covid-19 deaths and hospitalizations last year were among people 65 years and older.
freemalaysiatoday.com/category/world/2024/02/29/older-americans-advised-to-get-another-covid-shot-this-spring/
Covid vaccination: Pfizer, Biontech and Moderna need no pity: Many people are still infected with the coronavirus. However, the willingness to be vaccinated has ...
nzz.ch/meinung/covid-impfung-pfizer-biontech-und-moderna-brauchen-kein-mitleid-ld.1768536
Quick Glance: Covid Vaccines: Pfizer, Biontech, Moderna's Remarkable Success
- Leading vaccine manufacturers Pfizer, Biontech, and Moderna are experiencing significant success.
- Last year, they generated double-digit billions with their mRNA vaccines against Sars-CoV-2.
- Moderna alone had a revenue of over $19 billion, Biontech received around 17 billion euros, and Pfizer accumulated a revenue of $5.6 billion.
- Pfizer made the most expensive acquisition in the pharmaceutical industry this year, totaling $43 billion.
Opinion | The Covid Vaccine Windfall Turns for Pfizer and Moderna: Reduced demand and revenue for the jabs isn’t bad news. The industry is working as it’s ...
wsj.com/articles/the-covid-vaccine-windfall-turns-on-pfizer-and-moderna-pandemic-booster-73b2903a
Pfizer struggles amid Covid decline: Pfizer's shares take a nosedive after a disappointing forecast for next year, revealing that its ambitious $43 billion ...
wionews.com/videos/pfizer-struggles-amid-covid-decline-670170
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
cnbc.com/2023/12/20/weight-loss-drugs-covid-downturn-pharma-had-a-year-full-of-firsts.html
Pfizer Stock Hits 3-Year Low—Down 50% From 2021 Peak: TOPLINE Pfizer shares tumbled again Monday, continuing the pharmaceutical giant’s struggles tied to ...
forbesafrica.com/current-affairs/2023/11/14/pfizer-stock-hits-3-year-low-down-50-from-2021-peak/
Pharma investment: courage is rewarded: The Mainz-based mRNA pioneer Biontech is a good example of how it can be worth taking risks in the volatile ...
faz.net/aktuell/wirtschaft/unternehmen/biontech-mut-wird-belohnt-19600734.html
Paid articlePaidQuick Glance: BioNTech Focuses on Cancer Drug Development after Revenue Plunge
- BioNTech reported a significant drop in revenue and earnings in 2023 as it shifts focus towards cancer drug development.
- The company aims for revenues between 2.5 billion to 3.1 billion euros in 2024.
- BioNTech plans to launch its first oncology drug in 2026 and secure ten indication approvals by 2030.
- Partner Pfizer anticipates a decline in sales for the COVID-19 vaccine, while BioNTech invests in scaling up its oncology business.
Pfizer's Doldrums, Just A Bad Case Of COVID-19?: Pfizer may be worth buying as the COVID-based product revenues decline and equilibrate ...
seekingalpha.com/article/4683994-pfizer-doldrums-just-a-bad-case-of-covid-19-pfe-stock
Paid articlePaid Covid patients who could benefit from paxlovid still aren’t getting it: During the pandemic, the federal government offered Americans a 5-day course of Paxlovid ...
texastribune.org/2024/03/13/grapevine-texas-covid-paxlovid/
Pfizer Covid jab to be sold in UK pharmacies: The drugs giant is in talks with high street chains to offer its vaccine privately from next month
thetimes.co.uk/article/pfizer-covid-jab-uk-sold-pharmacies-counter-vaccine-5jd6xtgfh
Paid articlePaid
It’s the last week to order free at-home COVID tests by mail: Final call: Request your free COVID-19 tests by mail before the federal program ends Friday.
sfchronicle.com/health/article/it-s-last-week-order-free-at-home-covid-tests-18707712.php
Paid articlePaid
Medigen to publish COVID-19 research on U.S. journal - Focus Taiwan: Taipei, Feb. 2 (CNA) A COVID-19 vaccine research from Taiwan-based Medigen Vaccine Biologics ...
focustaiwan.tw/sci-tech/202402020014
Pfizer sued Romania on anti-Covid jabs: Pfizer - BioNTech sued Romania to force it pay for all the anti-Covid vaccines it contracted following the protocol ...
romaniajournal.ro/society-people/pfizer-biontech-sued-romania-to-force-it-to-pay-for-the-anti-covid-vaccines-contracted-during-the-pandemic/
Dispute with Biontech: Federal Court declares Curevac's corona vaccine patent invalid
rundschau-online.de/wirtschaft/streit-mit-biontech-bundesgericht-erklaert-corona-impfstoffpatent-von-curevac-fuer-nichtig-705505
Quick Glance: Biontech Wins Lawsuit Against Curevac Patent
- Crucial part of competition between Biontech and Curevac
- Court rules in favor of Biontech in lawsuit against Curevac
- Dispute over substantial amount of money between Biontech and Curevac
- Biontech successfully invalidates fundamental Curevac patent
Pfizer: Profit slump of 93(!) percent: The American pharmaceutical giant Pfizer is feeling the effects of the reduced demand for Covid-19 medicines and vaccines.
deraktionaer.de/artikel/pharma-biotech/pfizer-gewinneinbruch-von-93-prozent-20349041.html
Expiring Pfizer Covid drug doses set to cost Europe $2.2bn: Soaring death counts spurred governments to invest heavily in Covid drug Paxlovid - but high vaccine ...
businesspost.ie/news/expiring-pfizer-covid-drug-doses-set-to-cost-europe-2-2bn/
Paid articlePaid Biontech and Pfizer are suing Poland and Hungary over corona vaccines: The background to the two lawsuits is an order for the corona vaccine developed by Pfizer ...
berliner-zeitung.de/news/biontech-und-pfizer-verklagen-polen-und-ungarn-wegen-corona-impfstoffen-li.2169960
Paid articlePaid
Expired Pfizer Covid antiviral drugs set to cost Europe €2bn: Millions of Paxlovid pills have gone unused as tight controls restrict access
irishtimes.com/business/2024/01/01/expired-pfizer-covid-antiviral-drugs-set-to-cost-europe-2bn/
Vaccine developer: EU patent office declares Moderna patent invalid: At the end of August, the US biotech company Moderna sued the Mainz company Biontech and its ...
handelsblatt.com/unternehmen/industrie/impfstoffentwickler-eu-patentamt-erklaert-moderna-patent-fuer-nichtig/29514290.html
Pfizer, BioNTech sue Poland and Hungary over Covid debts: EU countries ordered vaccines for their population through a joint purchase scheme.
freemalaysiatoday.com/category/business/2023/12/19/pfizer-biontech-sue-poland-and-hungary-over-covid-debts/
Pfizer: Slimming Down After COVID Franchise And Obesity Pipeline Setbacks: There is little Pfizer can do about the COVID franchise shortfall. Read more to see an ...
seekingalpha.com/article/4655688-pfizer-stock-slimming-down-after-covid-franchise-obesity-pipeline-setbacks-reaffirm-buy
Paid articlePaid Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics